The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.
Adult 18 and over
Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
Patient who agreed to participate to the research
Patient doesn't agree to participate to the research
People followed in unconventional structure care
Cohort
Prospective
Not listed
Number of RTDs performed compared to the number proposed
Evaluate the acceptability of simultaneous screening for viral hepatitis B, C and HIV among drug users in non-conventional structures using a dual method by RTDs and FibroScan®
Number of FibroScan® performed compared to the number proposed
Evaluate the acceptability of simultaneous screening for viral hepatitis B, C and HIV among drug users in non-conventional structures using a dual method by RTDs and FibroScan®
Number of days actually completed and the number of participants per session
Evaluate the feasibility of simultaneous screening for viral hepatitis B, C and HIV in drug users in non-conventional structures using a dual screening method TROD and FibroScan®
Number and proportion of patients having accepted the immediate consultation with the hepatologist and/or with an addictologist
Evaluate the acceptability of risk reduction methods as part of the care pathway.
Number of patients who had social care
Evaluate the impact of screening in terms of patient care.
Number of anti-viral B vaccinations offered and carried out
Evaluate the impact of screening in terms of patient care.
Click on the lead sponsor to view all of their trials.
